SynthesisPloS one2025

The efficacy of DPP IV inhibitors as adjunct therapy for patients with auto-immune Diabetes: A systematic review and meta-analysis.

Laurette Nakhoul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.